Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aryl Halides. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112573978B reveals a mild sulfoxide-catalyzed halogenation method offering high yields and selectivity for reliable pharmaceutical intermediate supplier applications.
Novel metal-free method constructs aromatic bonds under air. Reduces cost and simplifies supply chain for electronic chemical manufacturing partners.
Patent CN1634810A details a mild CuI-amino acid catalytic system for alkyne-aryl coupling, offering significant cost reduction in API manufacturing and high-purity intermediates.
Advanced Cu-catalyzed coupling method reduces temperature by 20°C. Offers cost-effective synthesis for high-purity pharmaceutical intermediates with reliable supply chain continuity.
Patent CN115010563B reveals a green nickel-catalyzed halogen exchange method. This technology offers cost reduction in pharmaceutical intermediate manufacturing via mild visible light conditions.
Patent CN107325002A details a green silver-catalyzed decarboxylative halogenation route. This method offers cost reduction in pharma intermediate manufacturing and enhanced supply chain reliability.
Patent CN107325002B details a green Ag/Cu-catalyzed decarboxylative halogenation method. It offers cost reduction in pharmaceutical intermediate manufacturing using cheap halide salts.